Back

The effect of canakinumab on COVID19-associated cardiomyocyte contractile dysfunction and arrhythmias

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: COVID-19 and basic science Arrhythmias ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Mr Sanzio Dimai

Nuremberg (Germany)

4 More presentations in this session

Presentation thumbnail
Erythrocytes induce vascular dysfunction in COVID-19
Mr A. Mahdi (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Novel SARS-CoV-2 variants induce higher toxicity in cardiovascular cells
Doctor J. Wagner (Frankfurt, DE)
Abstract Slides Video
Presentation thumbnail
The SARS-CoV-2 Spike protein alters human cardiac pericyte function and interaction with endothelial cells through a non-infective mechanism involving activation of CD147 receptor signalling
Doctor E. Avolio (Bristol, GB)
Abstract Slides Video
Presentation thumbnail
Expressing a truncated SARS-COV-2 spike protein in mouse heart induces cardiac hypertrophy
Assistant Professor Z. Lin (Utica, US)
Abstract Slides Video

Access the full session

Session thumbnail
COVID-19 and basic science

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Congress Session
Risk stratification
thumbnail
Congress Presentation
Anatomical correlates of VF ablation 
thumbnail
Congress Session
Malignant arrhythmias

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources